Installed Building Products, Inc. (NYSE: IBP) — A Through-Cycle Compounder Marked Down as a Pure Cyclical

Independent fundamental equity research. Report date: 2026-06-14. As-of price: $207.09 (2026-06-12).

⚡ Claude’s Take

This block is the author’s own independent opinion — general information, not investment advice. The analysis that follows takes no position and carries no price target.

Verdict: CONSTRUCTIVE — BUY / accumulate. A proven, high-quality compounder sold ~50% in a rate-driven housing air pocket, not a broken business. Conviction: MEDIUM-HIGH (higher than the typical cyclical, because the quality is demonstrated through the downturn and the balance sheet is a fortress).

The single most useful fact about Installed Building Products is what its returns did when its end market fell apart: single-family starts dropped ~17% from the 2021 peak, IBP’s organic volume went negative for three straight years — and ROIC still held a ~17% plateau (management cites >20%), gross margin actually expanded to 34%, and FCF hit a record ~$300M. That is not how a commodity labor-arbitrage business behaves; it is how a disciplined #2-in-a-duopoly behaves. The market, having bid IBP to ~$300+ as a compounder, has now re-rated it to ~$207 (≈12x EV/EBITDA, ~19x adjusted earnings, ~5.4% FCF yield) as if it were a pure cyclical. The tell that this is a cyclical air pocket and not a structural break: the stock’s alpha is ~zero (−0.05) — the decline is almost entirely the housing/rate factors turning against it, not idiosyncratic deterioration — and its one-, three-, five- and ten-year returns are all still solidly positive. The clinching anchor arrived in April: QXO agreed to buy TopBuild — the #1 installer, IBP’s larger twin — at 14.9x EBITDA, while IBP, with comparable margins and ROIC, trades at ~12x. The quality premium IBP used to carry has compressed to a discount to where the sector’s leader just changed hands.

My framing is quality-compounder-on-sale, with a dash of special-situation optionality (a credible take-out floor now exists). It is not a screaming deep-value bargain — 19x adjusted earnings into a starts trough is a fair, not cheap, absolute price, and the bear case (negative organic volume, peak margins, growth that is now 100% acquisition, a dead energy-code tailwind, and a CEO who sold $125M near the top) is real. But the asymmetry is attractive: my base-case fair-value zone is ~$230–270 on a normal cycle (≈12x a normalized ~$580–600M EBITDA), with a bull path toward $350+ if starts recover and the multiple re-rates toward the TopBuild take-out, against a bear floor near ~$130. Conviction flips bullish on stabilizing single-family starts with positive same-branch volume at ~17–18% margins (or a strategic bid); it flips bearish if EBITDA margin breaks below ~16% for multiple quarters or M&A multiples paid climb toward 8–10x as strategics bid up the tuck-in pipeline. Tag: “The #2 installer on the discount rack while #1 sells for 15x.”

1. Executive Summary

Installed Building Products is the #2 U.S. residential insulation installer (behind TopBuild), a founder-led serial acquirer that has rolled up ~200+ local installation businesses since the 1990s and compounded revenue at ~12–13% over the past decade. It generated ~$2,971M of FY2025 revenue at a 34.0% gross margin and 17.9% EBITDA margin, $265M of net income ($9.71 GAAP / ~$10.83 adjusted EPS), and ~$301M of free cash flow. Unlike a distributor, IBP sells installed labor plus materials — it buys fiberglass and foam from an oligopoly of suppliers (Owens Corning, Knauf, CertainTeed, Johns Manville) and installs them with variable, piecework crews. That variable-cost model is the structural reason its margins flex far better than a fixed-cost manufacturer-distributor’s.

The investment question is whether a high-quality, proven compounder, sold ~50% from its highs, is now mispriced as a pure cyclical. The evidence for quality is strong and specific. Through a three-year housing downturn in which IBP’s organic (same-branch) volume was negative every year (−8.4% / +0.2% / −5.7% in 2023/24/25), the company still: held ROIC on a ~17% plateau (2022–2025), expanded gross margin ~640bps over the cycle to 34.0%, raised price/mix every single year, grew the counter-cyclical commercial segment (+10–22% same-branch), generated record FCF, and kept net leverage near ~1.0–1.2x against a ~2x target. This is the resilience signature of a real local-scale franchise, not a commodity business.

What makes the setup timely is valuation context. After the drawdown, IBP trades at ~12x EV/EBITDA — essentially its own 10-year average — and a P/E in the 29th percentile of its own history (cheap on earnings), even as those earnings sit on near-peak, downturn-tested margins (i.e., this is not a depressed-earnings/inflated-P/E trough trap like a pure-cyclical distributor). The decisive comp: in April 2026 QXO agreed to acquire TopBuild, the #1 installer, at 14.9x EBITDA (~$17B); IBP, with a 17.9% EBITDA margin vs TopBuild’s ~17.4% and comparable ROIC, trades two-plus turns cheaper and now carries genuine take-out optionality.

The bear case is not trivial and the memo gives it full weight: organic volume has been negative for years and 2025’s headline growth was 100% acquisition-funded; incremental operating margins were already negative in 2025, so peak margins have more downside than upside; the energy-code content-growth tailwind IBP long cited was just rescinded by HUD/USDA; the CEO sold 400,000 shares (~$125.6M) near the March-2026 peak; and big-box capital is circling the installation channel (Lowe’s bought installer Artisan Design Group; QXO is buying TopBuild). Below this line the memo takes no position and names no target; it lays out the mechanism, the numbers, and the falsification tests on both sides.

2. Business Overview

What it does. Installed Building Products installs insulation and a range of complementary building products into primarily residential structures across the United States. It is the country’s #2 residential insulation installer. Founded by the Edwards family (CEO Jeffrey Edwards), headquartered in Columbus, Ohio, IPO’d in 2014, it operates ~250 branch locations with ~10,800 employees. (FACT: FY2025 10-K, filed 2026-02-26.)

Segments. Three reportable segments, but the company is overwhelmingly an installer:

• Installation (~low-90s% of revenue) — the core: insulation plus complementary products, installed by IBP crews.
• Distribution (~5% of revenue) — wholesale of insulation and accessories.
• Manufacturing (single-digit %) — cellulose insulation and certain components.

Revenue mix by product. Insulation installation is ~58% of net revenue (down from a historical ~74% as IBP deliberately diversifies); complementary products are ~6% and growing — waterproofing, fire-stopping/fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors, and after-paint. None of the complementary lines is individually significant, which is the point: each is a cross-sell into the same builder relationship and branch infrastructure. (FACT: FY2025 10-K.)

End markets. Residential new construction plus repair/remodel is ~76% of revenue (both 2024 and 2025); commercial is ~17% (up from ~11% in 2013 — a deliberate, counter-cyclical diversification); the remainder is other. The dominant demand driver is single-family new construction, where insulation is a code-required, non-deferrable, early-phase trade. Top-10 customers are ~14% of revenue — low concentration. (FACT: FY2025 10-K.)

The model distinction that matters. IBP sells installed labor plus materials, not delivered product. It purchases insulation from an oligopoly of manufacturers (three suppliers ≈ 35% of purchases) and installs it with crews paid largely on piecework (“by the completed job”). This is the central economic difference from a manufacturer-distributor such as Builders FirstSource: IBP’s largest variable cost — labor — flexes down with volume, so when starts fall, a meaningful chunk of the cost base falls with them. That is the mechanical basis for the cyclical-margin resilience documented throughout this memo. (FACT: FY2025 10-K.)

How it makes money. Gross profit is the spread between the installed price (labor + materials + margin) charged to the builder and IBP’s material and crew costs; the business converts that into industry-leading FCF because it is asset-light (capex ~2.4% of sales) and because acquisition intangible amortization depresses GAAP earnings well below cash generation.

Branch economics, concretely. Each of IBP’s ~250 branches is effectively a local installation business: a stocking/dispatch location, a fleet, and crews serving a delivery radius. The unit economics are driven by crew utilization and local density — the more homes a branch installs within its radius, the better it amortizes its fixed branch overhead and fleet, and the more purchasing volume it concentrates with the material suppliers. This is why the moat is local (see Competitive Position): national revenue is the sum of local densities, and a branch with #1 share in its metro earns structurally better margins than a sub-scale local competitor. The decentralized model — acquired businesses keep their local brands and management — is deliberate: it preserves the local builder relationships and crew networks that are the actual asset, while head office supplies purchasing scale, capital, and best-practice pricing discipline.

Why diversification is strategic, not just opportunistic. The push of insulation from ~74% to ~58% of revenue, the build of complementary products to ~6%, and commercial to ~17% are not random adjacencies — each rides the same branch infrastructure and builder relationship, so incremental products drop through at attractive incremental margins while diluting pure single-family-insulation cyclicality. Commercial in particular has a different, longer cycle (driven by non-residential construction and backlogs rather than mortgage rates), which is why it grew +20–38% same-branch through 2025–26 exactly as residential fell — a genuine, structural counter-cyclical offset rather than a coincidence.

Verdict: A focused, asset-light, founder-led residential installation franchise — #2 nationally in insulation — with a variable-cost labor model and a deliberate, branch-leveraged diversification into commercial and complementary products that materially dampens (without eliminating) its single-family-construction cyclicality.

3. Industry Dynamics

Structure — a two-firm national top tier over a fragmented tail. Residential insulation installation is led by two national players — TopBuild (#1) and IBP (#2) — sitting above “one other large national contractor, several large regional contractors, and numerous local contractors” (10-K). This is the most attractive structural feature of the industry: a stable, rational, duopoly-at-the-top in which the two leaders consolidate a long fragmented tail rather than fighting a winner-take-all war. The two leaders combined still hold a minority of a large national market, so the consolidation runway is long. (FACT: FY2025 10-K.)

Demand driver — single-family starts, but non-deferrable. The prime mover is single-family housing starts, which fell from a 1,127k peak (2021) to ~941k (2025), ~17% below peak and below the ~1.1–1.5M level implied by household formation — mid-trough, not peak, with mortgage rates ~6.5–7% gating affordability. But insulation is code-required and early-phase: it goes into essentially every new home and cannot be value-engineered out, so demand tracks starts closely without the discretionary skew of, say, a kitchen remodel. (FACT: FY2025 10-K; U.S. Census/NAHB; cross-read from the BLDR report.)

The labor constraint and material oligopoly. The binding input is skilled installation labor; the binding cost risk is that IBP cannot always pass material inflation through “due to the fragmented and competitive nature of our industry” (10-K). Fiberglass is supplied by an oligopoly (Owens Corning, Knauf, CertainTeed, Johns Manville), so material pricing is partly pass-through and partly contestable — a dynamic to watch, since the suppliers’ pricing power is the mirror of IBP’s.

Energy-code tailwind — now rescinded (important downgrade). IBP has long cited rising energy codes (IECC) as a structural, starts-independent content-growth driver — more insulation required per home. This thesis pillar must be removed: the 2024 IECC actually loosened some residential ceiling thresholds, and in 2026 HUD/USDA issued a Joint Determination rescinding in its entirety the prior 2021-IECC adoption mandate for FHA/USDA single-family housing (HUD-NO-26-029). The content-growth tailwind is, for now, dead — a genuine negative for the long-run organic-growth story. (FACT: HUD/USDA determinations, 2026.)

Capital-cycle read (Marathon). Two opposing forces. On the constructive side, unlike the building-products distribution channel — which drew ~$40B+ of strategic capital in 2024–25 (Home Depot/SRS+GMS, Lowe’s/Foundation, QXO/Beacon) — the installation niche has historically attracted no big-box entrant, because retailers want distribution assets, not labor-management businesses. That left the pricing umbrella intact and explains how the two leaders earned high returns through the downturn. On the cautionary side, that is now changing at the top end: Lowe’s bought installer Artisan Design Group (2025), and QXO is acquiring TopBuild (2026) — strategic capital is finally entering installation, which over time could bid up the tuck-in pipeline that fuels IBP’s roll-up arbitrage.

The TopBuild take-out reframes the industry. QXO’s agreement to acquire TopBuild at ~14.9x EBITDA is more than a comp — it is a statement about how a sophisticated strategic consolidator values the #1 installation franchise, and it changes the industry’s forward structure. Three implications follow. First, it validates that the installation model — long ignored by big-box because it is labor- rather than distribution-centric — is now seen as a platform worth ~$17B, confirming the niche’s profit-pool durability. Second, it removes the larger of the two rational duopolists into private/strategic hands, which could either intensify competition (a deep-pocketed QXO pushing TopBuild harder on M&A and pricing) or stabilize it (QXO running TopBuild for returns rather than share). Third, it tightens the M&A funnel: with two strategic buyers (QXO via TopBuild, Lowe’s via ADG) now active in installation tuck-ins, IBP may face higher prices for the local installers that fuel its roll-up — the single biggest risk to its multiple-arbitrage engine. The net is a more valuable but more contested industry.

Verdict: structurally GOOD-to-MIXED — and better than building-products distribution. A consolidated top tier, non-deferrable code-required demand, a variable-cost model, and (until recently) no big-box intrusion together produced ~17% through-cycle ROIC for the leaders. The offsets are real: single-family cyclicality is unavoidable, material pass-through is contestable, the energy-code tailwind has been rescinded, and strategic capital is beginning to enter the niche. On balance a structurally sound industry for the scaled leaders, with a demand cycle that is exogenous and currently adverse.

4. Competitive Position

The moat, named. In Greenwald’s taxonomy IBP’s advantage is local economies of scale plus density, reinforced by two supports a local installer cannot match: scale purchasing of insulation from the supplier oligopoly, and national-builder relationships (a national installer can single-source a production builder across many markets — operationally valuable to a D.R. Horton or Lennar building in dozens of metros). IBP holds #1 or #2 share in more than half of its local markets; share at the local level is what generates route density, crew utilization, and purchasing leverage.

The tests. The market-share-stability test fails at the national level — IBP’s share was assembled via 200+ acquisitions, the hallmark of a roll-up rather than organic industry-wide barriers — but passes locally, where #1/#2 positions persist. The ROIC test passes decisively and is the strongest single piece of evidence for the moat: IBP earned ~17.5% / 17.7% / 17.5% / 17.1% ROIC across 2022–2025, well above an ~8–9% WACC, through the housing downturn. A genuinely commodity, no-barrier labor business does not sustain ~17% ROIC for four years while its end market shrinks. (Note: pre-2022 ROIC was 11–13%; the ~17% plateau is a post-scale phenomenon, which both validates “economies of scale” and cautions that the plateau is recent.)

The bear’s case, fairly stated. Installation is low-capital and, in principle, contestable — a builder can switch installers, and crews can be hired by a competitor. The advantage is local and must be re-won market by market; it is narrow, not wide. The rebuttal is empirical: contestable low-barrier businesses do not earn 17% ROIC through a downturn. The truth is in between — a real but narrow, local, scale-and-relationship moat, durable in the markets where IBP has density and weaker where it does not.

IBP vs TopBuild (#1). TopBuild is ~1.8x IBP’s size (~$5.4B revenue vs ~$3.0B) at a slightly higher ~17–20% EBITDA margin, with a larger specialty-distribution arm (more channel-diversified); IBP is the focused pure-play #2. Both roll up the same fragmented tail. This is a rational duopoly, not a share war — and QXO’s 14.9x take-out of TopBuild is a direct read-through to IBP’s franchise value.

IBP vs BLDR (the distinction that drives the thesis). Same exogenous driver (single-family starts), very different earnings behavior. BLDR is a fixed-cost manufacturer-distributor whose ROIC collapsed to 7.4% at the trough (operating income −80% on revenue −33%), carries ~3.2x trough leverage and negative tangible book, pays no dividend, and posted a Q1 2026 GAAP loss. IBP’s variable piecework labor, annual price increases, commercial/complementary diversification, and low capital intensity held ROIC at ~17% and produced record FCF through the same downturn. IBP trades richer on headline P/E (~19x adjusted vs BLDR’s ~11–15x) but on demonstrably more stable through-cycle returns and a far stronger balance sheet — the quality premium is earned.

Why national scale beats a local installer — the relationship mechanism. The clearest source of IBP’s edge is its ability to serve a national production builder across many markets with one contract, consistent crews, and consistent quality/warranty. A D.R. Horton building in 40 metros cannot efficiently contract 40 separate local insulators; it wants a national partner that can guarantee schedule adherence (insulation gates the drywall trade behind it, so a late insulation install delays the whole build) and code compliance. A purely local installer, however good, simply cannot offer that. This is a real, structural advantage — but note its limit: it is strongest with the large production builders (precisely the customers, ~14% of revenue, whose volume fell hardest in this downturn) and weaker with custom/regional builders, where local relationships and price matter more and a national installer’s overhead is a disadvantage. The moat is thus concentrated where the cyclicality is sharpest — a nuance the bull case should not gloss over.

Verdict: durable but narrow advantage — not a commodity business, not a wide moat. The local scale/density/relationship moat is real and is proven by ~17% through-cycle ROIC and downturn margin expansion; it is also local, narrow, and reliant on continued M&A discipline to extend. IBP is the higher-quality, less-cyclical play in the housing complex, priced — after the drawdown — at a discount to where its #1 peer is being acquired.

5. Growth History and Forward Opportunities

History — a compounding roll-up. Revenue compounded ~12.8%/year from 2017 to 2025 ($1.34B in 2018 → $2.97B in 2025), driven by a steady cadence of tuck-in acquisitions layered on top of a housing-cycle-sensitive organic base. The growth engine is the acquisition machine: a standing goal of acquiring ≥$100M of annualized revenue per year, executed at low multiples (below).

The quality caveat — organic is currently negative. This is the most important thing to understand about IBP’s growth right now, and the memo will not let the headline obscure it. Installation same-branch (organic) volume was negative in each of the last three years (−8.4% / +0.2% / −5.7% in 2023/24/25), while price/mix was positive every year (+7.2% / +3.7% / +1.6%). In 2025, consolidated organic revenue actually shrank −1.3%; the headline +1.0% total growth was entirely acquisition-funded. The resilience story (margins, ROIC, FCF) is real, but it is a margin and returns resilience, not a revenue one. A thesis that conflates acquisition-funded revenue with organic strength is mistaken; the organic top line needs a housing recovery to inflect positive.

The bright spot — commercial. Heavy-commercial same-branch grew +30% (Q3’25), +38% (Q4’25), and +22% (Q1’26) on a growing backlog, broad across education, healthcare, manufacturing, and offices (notably not data-center-driven, so not dependent on that one hot end-market). Commercial is the counter-cyclical offset to residential weakness and a deliberate diversification.

Forward opportunities. (1) Tuck-in M&A — the core compounding lever, a long runway against a fragmented tail at 4–6x EBITDA (multiple arbitrage into a ~12x multiple). (2) Complementary-product cross-sell — pushing more non-insulation products through existing branches and builder relationships, lifting revenue per start and diluting insulation-cycle dependence. (3) Commercial expansion — organic and via M&A (management eyes commercial roofing and mechanical/industrial as a “third leg”). (4) Cyclical recovery — the largest single swing factor: a return of starts toward 1.0–1.1M would turn organic volume positive and drop through high-incremental-margin. (5) Spray foam pricing — two ~25% supplier increases management expects to largely stick, aiding 2H26 price/mix. The removed energy-code tailwind is a genuine subtraction from this list.

Verdict: mixed quality — high-quality engine, currently stalled organic. The acquisition compounding and complementary/commercial diversification are high-quality, durable levers; but organic same-branch growth is negative and dependent on an exogenous housing recovery, and the energy-code content tailwind is gone. Growth quality improves materially the moment starts inflect; until then, IBP is compounding per-share value through M&A and buybacks on a flat-to-declining organic base.

6. Financial Quality

Multi-year financials (FY, $M; reconciled to 10-K, cross-checked vs ROIC.ai):

Income statement — margin expansion through a volume downturn. Gross margin expanded ~640bps over the cycle (27.8% in 2018 → 34.0% in 2025) and EBITDA margin held a tight 17.7–17.9% across 2023–25 despite flat-to-down volume. The mechanism: IBP raised price/mix every year even as same-branch volume fell, and its variable piecework labor let crew costs flex down. The caution: incremental operating margin was actually negative in 2025 (operating income flat on revenue up 1%), which tells you margins are at/near a cyclical ceiling — the upside from here is volume recovery, not further margin expansion, and the near-term risk is margin give-back if volume falls further (Q1’26 adjusted gross margin was 32.2% vs a Q4’25 record 35.0%).

Cash flow — high quality, capex-light. CFO exceeds net income every year (1.1–1.9x), with the gap largely non-cash acquisition intangible amortization. Capex is ~2.4% of sales. FCF was a record ~$301M in 2025 (~10% of revenue, ~$11/share). Net income does not diverge below cash — the opposite, in fact: cash generation runs ahead of reported earnings.

Balance sheet — a fortress for a cyclical. Net debt/EBITDA was ~1.0–1.2x at year-end 2025, well inside the ~2x target — a full turn of unused capacity. Interest coverage was ~16.8x; the revolver/ABL is undrawn (upsized and extended to 2031); in January 2026 IBP issued $500M of 5.625% notes due 2034 and repaid its 2028 notes, leaving no maturity wall and ~$900M of liquidity. Goodwill + intangibles are ~34% of assets / ~100% of equity, so tangible book is roughly zero-to-negative and P/B is ~8.4x — the standard signature of an asset-light, buyback-heavy roll-up, not a red flag; this business must be judged on ROIC and FCF, not book value.

Returns. ROIC stepped onto a ~17–18% plateau in 2022 and held it (17.5 / 17.7 / 17.5 / 17.1%) through 2023–2025 — the single best evidence of franchise quality and the cleanest contrast with BLDR’s collapse to 7.4%. (Management cites FY2025 ROIC of ~24% on its own definition; even the more conservative ROIC.ai-reconciled ~17% clears WACC comfortably.) ROE is high but distorted by the small, buyback-shrunk equity base.

Quality of earnings — high, and GAAP understates it. Diluted share count fell ~14% (31.8M → 27.3M) on ~$468M of cumulative buybacks (2021–25); SBC is modest (~0.7% of sales). Critically, acquisition intangible amortization of ~$41M understates GAAP EPS by ~$1.12/share after tax (~12% of net income): adjusted diluted EPS is ~$10.83 vs GAAP $9.71, lowering the P/E from ~22x to ~19x. Accounting looks conservative — short intangible lives, no goodwill impairments, point-in-time revenue recognition, CFO > NI. One item to monitor (handed to Capital Allocation): earnout/contingent-consideration remeasurement should not be flattering operating income.

The incremental-margin tell. The most important nuance in the financials is the direction of incremental margins. From 2022 to 2025 IBP expanded EBITDA margin even as volume fell — but examine 2025 alone: revenue rose ~1% while operating income was flat, i.e., the incremental operating margin on that marginal revenue was roughly zero-to-negative. This is the signal that margins are at a cyclical ceiling: the early-downturn margin expansion came from price/mix outrunning a still-elastic cost base, but cost inflation (vehicle/medical/liability insurance, diesel) has now caught up, and with same-branch volume negative there is no volume leverage to offset it. The investment implication is precise: do not extrapolate further margin expansion; the upside from here is a volume recovery dropping through at high incremental margins, while the near-term risk is modest margin give-back (Q1’26’s 32.2% adjusted gross margin vs Q4’25’s 35.0% record shows the sensitivity).

The GAAP-to-cash bridge. IBP is a case study in why GAAP understates a roll-up’s earnings. Acquisition intangible amortization (~$41M in 2025) is a non-cash charge that recurs as IBP keeps acquiring, depressing reported EPS by ~$1.12/share after tax (~12% of net income) — yet it corresponds to no cash outflow and no economic deterioration (the acquired customer relationships are, if anything, appreciating as IBP cross-sells). Hence CFO runs 1.1–1.9x net income, and the honest earnings figure is the ~$10.83 adjusted EPS, not the $9.71 GAAP number. This single adjustment moves the P/E from ~22x to ~19x and is the difference between “expensive cyclical” and “fairly priced compounder.” The discipline for the analyst: verify the amortization is genuinely acquisition-related (it is) and that the add-back is not masking a real, recurring cost of replenishing the business (capex at ~2.4% of sales confirms the maintenance burden is low and separately funded).

Working capital and counter-cyclicality. Like other building-products names, IBP’s working capital releases cash in a downturn (receivables and inventory shrink with volume), which is part of why FCF hit a record ~$301M in 2025 even as the top line stalled — and why it would temporarily consume cash in a sharp recovery. The conservative balance sheet (~1.0–1.2x net leverage) means this counter-cyclical cash, plus the ~$900M of liquidity and the dry-powder buyback authorization, lets IBP buy both businesses and its own stock at the cyclical low — the structural advantage of entering a downturn under-levered.

Verdict — economics improve with scale, and earnings are high-quality. Scale lifted gross margin +640bps and ROIC from ~12% to ~17%; the business throws off cash well in excess of reported earnings, carries little debt, and shrinks its share count. The honest qualifier: the margin/ROIC engine is at a cyclical ceiling with negative incremental margins at flat volume, and organic revenue is currently shrinking. High-quality, downturn-tested earnings — judged correctly on adjusted EPS, ROIC, and FCF, not on GAAP P/E or book value.

7. Capital Allocation

Capital allocation is IBP’s defining strength, and it rests on three legs: a value-creating acquisition machine, a distinctive cyclical dividend policy, and opportunistic buybacks — all funded from FCF with conservative leverage.

M&A — value-creating multiple arbitrage. IBP has completed 200+ acquisitions, buying small local installers at ~4–6x EBITDA and folding them into a platform that trades at ~12x (and traded >15x at the highs). That arbitrage — buying private at single digits, capitalizing it at the public multiple — is the largest single source of per-share value, and the proof it is disciplined rather than empire-building is that goodwill is only ~22% of assets, with most consideration in identifiable, customer-backed intangibles (cheap, asset-backed prices). The model is decentralized: acquired local brands and management are retained. Cadence:

Management guides to “at least $100M annual revenue” acquired in 2026 — the compounding continues even with a soft organic base. The watch item (per the capital-cycle read): if QXO/Lowe’s bid up installation assets, IBP’s entry multiples could rise and erode the arbitrage.

Dividends — a distinctive dual policy fit for a cyclical. IBP pays a regular quarterly dividend plus a variable annual special (paid each March, in place since 2022) that flexes with free cash flow — exactly the right structure for a cyclical, committing only a modest fixed payout while returning surplus FCF opportunistically:

The payout is ~33% of net income; the forward all-in yield is ~1.6% at $207.

Buybacks — opportunistic, leaning into the dip. Repurchases were $137.6M (2022), $6.3M (2023), $145.3M (2024), and a record $172.6M (2025), shrinking the share count ~9%. A new $500M authorization was approved in February 2026, just ahead of the drawdown to $207 — dry powder to buy weakness (only ~$25M used in Q1’26, so most remains). One governance note: some repurchases have been discounted private blocks from the CEO’s holding entity (related-party, at/below market — disclosed).

Leverage — conservative, with dry powder. Net debt/EBITDA ~1.0–1.2x vs a ~2x target leaves roughly a full turn of unused capacity; capital returns and M&A are funded from FCF, not incremental leverage, with no equity issuance.

Capex — asset-light confirmed. ~2.4% of sales (~$71M on ~$3.0B in 2025); net PP&E just ~$282M.

Insider activity — two-sided, net-encouraging but with a blemish. The blemish: founder/CEO Jeffrey Edwards sold 400,000 shares on March 3, 2026 at ~$314 (~$125.6M), cutting his stake ~18.8%, days after the Q4 print and near the 6-month peak — optically poor, though he still holds ~13.1% (~3.5M shares), remaining the largest individual holder, and the sale reads as diversification, not distress. The counter-signal: after the drop, an open-market buy cluster on May 12, 2026 at ~$204–218 — CFO Miller (~$450K), COO Wheeler (~$150K), CAO Niswonger (~$98K), and a director (~$98K). The operating team bought where the CEO sold the top.

Incentive comp (2026 proxy). Long-term incentive metrics are Adjusted EBITDA, revenue, and adjusted G&A % of revenue; the annual cash bonus is on financial goals (50% threshold, 200% cap). ROIC (>20% on management’s definition) is a stated narrative anchor but not a formula metric — a mild weakness, as EBITDA/revenue metrics can reward dilutive growth; the founder’s ~13% stake is the stronger alignment. CEO 2025 total pay was ~$9.7M, with clean governance hygiene (ownership requirements, clawback, no gross-ups/single-trigger), the one flag being a pledging exception for the CEO/one director.

The compounding flywheel, quantified. Put the legs together and the per-share engine is clear even with a stalled organic base. IBP generates ~$300M of FCF; it directs roughly a third to dividends (~$89M), deploys ~$50–90M to acquire ~$100M+ of revenue at 4–6x (creating value instantly versus its ~12x multiple), and uses the balance plus balance-sheet capacity for buybacks (~$173M in 2025). The acquisitions add EBITDA; the buybacks shrink the share count (~14% since 2021); the dividend returns surplus cash without over-committing a cyclical. Each turn of the flywheel raises per-share intrinsic value by more than the organic business alone would — which is precisely how IBP delivered ~21%/year ten-year returns while its end market was, for much of that period, below its prior peak. The risk to the flywheel is narrow and identifiable: it depends on continued availability of cheap tuck-ins, which the entry of QXO and Lowe’s into installation M&A could compromise.

Verdict: management has allocated capital intelligently — among the best in building products. The roll-up is genuine, disciplined multiple arbitrage (low goodwill, retained ROIC); the dual dividend is well-designed for a cyclical; buybacks are opportunistic with fresh dry powder; leverage is conservative; and the founder is heavily aligned. The two fair criticisms are the CEO’s top-tick sale and the absence of a hard ROIC metric in the formula comp.

8. Changes and Headwinds — Last Two Years

The ~50% drawdown and its trigger. IBP fell from ~$300+ to ~$207 over six months. The proximate triggers were the Q4 2025 print (which flagged a weak, weather-hit Q1) and especially the Q1 2026 results on May 7, 2026 — a revenue and gross-margin (32.2% vs ~34% expected) disappointment that sent the stock down ~10–11% on the day. This is a cyclical/expectations reset, not a disclosure of structural deterioration.

The residential trough vs the commercial offset. Q1 2026 consolidated sales fell 4% to $661M; same-branch −6%, volume −10% (with ~$20M of weather loss). New-residential same-branch was −11%, concentrated in entry-level/production builders (~14% of revenue); private/custom builders were “relatively consistent” and turned positive in April 2026. Heavy-commercial same-branch was +22% on a growing backlog. Multi-family same-branch was −10% but with growing backlogs; management is “very confident” on 2027 multi-family, cautious on 2H26.

Cost inflation. Management flags persistent non-controllable cost inflation “that follows us all year” — vehicle insurance +25%, diesel +$15–20M, medical +40%, liability +35%, aluminum/gutters +20% — pressuring margins even as product pricing holds (+70bps product margin despite −10% volume). Fiberglass supply is ample (a plant coming back online), so no residential fiberglass price increase is expected to stick; spray-foam increases (~25% x2) are expected to largely stick.

Energy-code tailwind rescinded. As noted above, HUD/USDA rescinded the 2021-IECC adoption mandate in its entirety (2026) — removing a long-cited structural insulation-content driver. A genuine negative.

CEO share sale. The $125.6M March-2026 sale near the peak (see Capital Allocation) is the most material governance event of the period — offset, but not erased, by the May operating-team buy cluster.

Competitive backdrop — strategic capital enters installation. Lowe’s acquired installer Artisan Design Group ($1.325B, ~$1.8B revenue, closed June 2025); QXO agreed to acquire TopBuild ($17B, 14.9x EBITDA, announced April 2026). Big-box/strategic capital is, for the first time, buying into the builder-installation channel — a long-run watch item (could professionalize competition and bid up M&A assets) but also a strong read-through to IBP’s franchise value and take-out optionality.

Balance-sheet de-risking. The January 2026 refinancing (2034 notes, ABL extended to 2031) pushed out maturities and added liquidity — a clear positive amid the downturn.

Verdict: net negative on a 6–12-month view, but mixed and largely cyclical. Weakening: a single-family/entry-level trough with no confirmed inflection, negative organic volume, cost inflation, the rescinded energy-code tailwind, the CEO’s top-tick sale, and big-box entry into the niche. Offsetting: structural commercial strength, private builders turning positive in April, demonstrated pricing discipline, a de-risked fortress balance sheet, aggressive capital return with fresh dry powder, a continuing M&A pipeline, and the post-drop insider buying. The changes confirm a high-quality compounder caught in a rate/affordability air pocket — they pressure the near term but do not break the franchise.

9. Risk Analysis (Risk Matrix)

Risk of permanent capital loss is lower than for a typical cyclical: the balance sheet is conservative, FCF is positive through the cycle, and ROIC held ~17% in the downturn. The realistic downside is a de-rating plus margin give-back scenario (toward ~$130, ~−38%) rather than impairment of the business; a total loss is highly improbable. The asymmetric risk is paying a fair-to-full ~19x adjusted earnings for a business at peak margins into a starts trough — i.e., a valuation/timing risk more than a solvency risk.

10. Valuation Discussion (Embedded Expectations)

No price target; embedded-expectations and scenario analysis only.

Current valuation, reconciled. At $207.09 × ~26.9M diluted shares = ~$5,571M market cap; plus net debt ~$706M ($1,180.6M debt − $474.3M cash) ⇒ EV ≈ $6,277M. On FY2025 EBITDA (~$531M) that is ~11.8x EV/EBITDA (≈12.0x on TTM EBITDA of ~$522M); EV/Sales ~2.1x; P/E ~19x adjusted / ~22x GAAP; FCF yield ~5.4% ($301M FCF / market cap). Crucially, ~12x sits essentially at IBP’s own 10-year average EV/EBITDA (~12.1x; range 7.1x–20.6x), and the P/E is in the 29th percentile of its own history. The “rich” reads — P/S in the 75th percentile, P/B ~8.4x — are artifacts of an asset-light installer with near-zero tangible book after buybacks, the wrong lenses for this model.

Not a trough-earnings trap. The key distinction from a pure-cyclical distributor: IBP’s ~12x is on resilient, near-peak-margin earnings (17.9% EBITDA, 34% GM, ROIC ~17% held through the downturn at mid-trough ~941k starts) — not on depressed earnings inflating the multiple. A starts recovery would raise EBITDA from here, not be required to justify the current multiple.

The decisive comp — the TopBuild take-out. In April 2026 QXO agreed to acquire TopBuild (the #1 installer) at 14.9x 2025 adjusted EBITDA (~11.8x post-synergies; ~$17B / $505/share). BLD’s standalone trading multiple was ~13.0x EV/EBITDA / ~19.6x P/E. The Lowe’s/Artisan Design Group installer deal was ~10.5x. So the strategic value of the #1 installer was just set at ~15x, and standalone trading at ~13x — while IBP, with a comparable (slightly higher) EBITDA margin and comparable ROIC, trades at ~12x. The historical quality premium IBP carried has compressed to a discount to its larger twin, and IBP now carries genuine take-out optionality.

Embedded expectations. Reverse-engineered, ~12x on resilient earnings, ~19x adjusted, ~5.4% FCF yield prices roughly flat-to-slightly-declining organic volume with margins holding near peak, plus continued ~$100M+/yr tuck-in M&A. The price is not underwriting a starts recovery toward 1.0–1.1M, not crediting any re-rate toward the 14.9x sector take-out, and not pricing IBP’s own take-out optionality. It is a “no-housing-recovery, maybe-modest-decline” multiple on proven-resilient earnings — a favorable asymmetry, provided one accepts that the absolute multiple (19x adjusted) is fair rather than cheap.

Walking the embedded-expectations math. Take the ~$6.28B EV. IBP’s M&A algorithm alone — ~$100M+ of acquired revenue per year at ~17–18% incremental EBITDA margins, bought at 4–6x — adds roughly $18–20M of EBITDA per year before any organic change, i.e., the platform grows EBITDA ~3–4%/year from acquisitions even if organic volume is flat-to-slightly-negative. Capitalize a normalized ~$580–600M EBITDA (modest organic normalization plus two-to-three years of that M&A accretion) at IBP’s own 10-year-average ~12x, net the ~$700M of debt, and divide by a buyback-shrinking ~25.5M shares, and the math lands in the mid-$200s — without assuming any multiple re-rating toward the 14.9x sector take-out and without a starts boom. For the current ~$207 to be the right price, one must believe either that organic volume keeps declining for years (plausible if rates stay high), that margins give back toward 16% (possible but fighting the demonstrated resilience), or that the multiple should sit below its own decade average despite the #1 peer being acquired two-plus turns higher. That is the crux of the variant: the price embeds a “no recovery, slight decline, no re-rate” path on a business that has compounded EBITDA through the worst housing tape in fifteen years.

Scenarios (3-year forward to FY2028 — scenarios, NOT targets):

The bear (~$129) requires a triple hit — a starts recession to ~800k, margin erosion to 16%, and a de-rate to 9x (below the 10-yr average) — and the margin leg is the least likely given proven downturn resilience. The base (~$255) is simply “modest normalization + IBP’s normal M&A algorithm + a multiple at its own 10-year average.” The bull layers a genuine starts recovery onto a re-rate toward the 14.9x sector take-out. The distribution is skewed up.

11. Variant Perception

Consensus belief. A good company whose upside is capped by the housing cycle; fairly valued at ~12x; the ~50% drop reflects rate-sensitivity, not business deterioration. The factor data supports that this is the consensus read of the tape: the decline is almost entirely factor-driven.

Strongest bull case. A structural compounder masquerading as a pure cyclical. ROIC held ~17% through the downturn (vs BLDR’s collapse to 7.4%); it compounds per-share value by buying private installers at 4–6x into a ~12x multiple; it returns cash aggressively (regular + variable-special dividend, record buybacks, fresh $500M authorization); it has a fortress balance sheet (~1.0–1.2x net leverage vs a 2x target, dry powder); and it now trades below its #1 peer’s trading multiple and well below the 14.9x at which that peer is being acquired — with genuine take-out optionality of its own. A starts recovery is upside the price does not require.

Strongest bear case. Same-branch volume has been negative for years and 2025 growth was 100% acquisition; margins are at a cyclical peak with negative incremental margins, so the next move is more likely down than up; the organic base is shrinking and the energy-code content tailwind that underpinned the long-run story has been rescinded; the M&A arbitrage erodes as QXO/Lowe’s bid up installation assets; the CEO sold $125M near the top; and at ~19x adjusted earnings into a starts downturn, the stock is fair-to-full, not cheap, on an absolute basis.

What the tape and factor loadings are pricing. IBP’s return record bifurcates sharply: deeply negative over three and six months (m3 −73% annualized, Sharpe −1.04; m6 −46%) but positive over every longer horizon (y1 +22.9%, y3 +22.2%/yr, y5 +13.3%, y10 +20.6%, all with positive Sharpes). The decisive datum is alpha of ~−0.05 (near zero) — versus BLDR’s −0.43: the decline is factor-explained, not idiosyncratic. The market is selling the housing/rate cycle (Home Construction beta +1.70, InterestRate −0.66), not re-rating the business — and the positive Quality (+0.42) and Value (+0.30) loadings say the franchise is still seen as high-quality and is now simply cheaper. This is the signature of a high-quality compounder in a rate-driven air pocket — “fallen quality” — not a broken falling knife. The rate-sensitivity cuts both ways: a Fed cut is a direct, identifiable catalyst.

The 3–5 assumptions that matter most: (1) single-family starts trajectory (the master variable); (2) whether EBITDA margin holds near 17–18% or gives back toward 16%; (3) M&A multiples paid (4–6x sustained vs creeping toward 8–10x as strategics enter); (4) the exit/re-rate multiple (toward the 14.9x take-out vs a value-trap de-rate); (5) the buyback/dividend pace through the trough.

Falsification. The bull is falsified if organic revenue turns sharply negative with EBITDA margin below ~16% for 2+ quarters, or if M&A entry multiples climb toward 8–10x. The bear is falsified if starts stabilize toward ~1.0M with positive same-branch volume at ~17–18% margins, or a strategic bid emerges near the BLD take-out multiple. Is consensus offsides? Likely, modestly — it correctly flags the cyclicality but under-weights the demonstrated earnings/ROIC resilience that decouples IBP from trough-multiple traps, and the re-rating signal from the 14.9x TopBuild take-out, which makes IBP’s ~12x look like a discounted #2. The near-zero alpha says: a quality cyclical sold with the cycle, with the quality now available cheap.

12. Fact vs. Interpretation Table

13. Open Questions

1. The single-family / multi-family / commercial revenue split in dollars — IBP discloses segment and same-branch detail but not a clean end-market dollar split; this is the key cyclicality-quantifying gap.
2. When does organic same-branch volume inflect positive? — entirely a function of starts and the entry-level builder recovery; private builders turned positive in April 2026, but production builders (~14% of revenue) remain weak.
3. Does the M&A arbitrage hold as QXO/Lowe’s enter installation — do entry multiples stay at 4–6x or creep toward 8–10x?
4. Margin trajectory — can IBP hold 17–18% EBITDA if volume falls further, or does non-controllable cost inflation grind it toward 16%?
5. Founder succession — CEO Edwards is the founder and largest holder; his $125M sale and the succession plan warrant monitoring.
6. Take-out optionality — does the QXO/TopBuild deal and big-box interest make IBP a target, and at what multiple?

14. What Must Be True

Bull case — what must be true:

• Single-family starts stabilize near current levels and recover toward ~1.0M, turning organic same-branch volume positive.
• EBITDA margin holds near 17–18% through the trough (variable labor + pricing discipline + commercial mix).
• IBP keeps acquiring ~$100M+ of revenue/year at 4–6x EBITDA, compounding per-share value, while buybacks shrink the share count.
• The multiple re-rates toward the ~13–15x where the sector’s #1 trades / was acquired.
• Falsification test: organic revenue turning sharply negative with EBITDA margin below ~16% for 2+ quarters, or M&A entry multiples climbing toward 8–10x, or the ~12x failing to re-rate as starts recover.

Bear case — what must be true:

• Mortgage rates stay elevated and single-family starts remain depressed or fall further, extending negative organic volume.
• Peak margins give back toward 16% as cost inflation outruns pricing in a weaker volume environment.
• The M&A arbitrage erodes as strategic capital (QXO, Lowe’s) bids up the installation tuck-in pipeline.
• At ~19x adjusted earnings into a trough, the stock de-rates further toward its historical low multiple.
• Falsification test: starts stabilizing toward ~1.0M with positive same-branch volume at ~17–18% margins, or a strategic bid emerging near the BLD take-out multiple, or the near-zero alpha turning positive as the franchise re-rates.

15. Source Appendix

See the separate Source Appendix (Appendix B below) for the full, dated source list. Primary sources: IBP FY2025 10-K (filed 2026-02-26), Q1 2026 10-Q (filed 2026-05-07), DEF 14A (2026), 8-Ks and Form 3/4/5 corpus (2021–2026); Q3 2025, Q4 2025, and Q1 2026 earnings-call transcripts (CEO Jeffrey Edwards, CFO Michael Miller); U.S. Census/NAHB single-family starts; HUD/USDA energy-code determinations (HUD-NO-26-029); QXO/TopBuild and Lowe’s/Artisan Design Group transaction reporting; ROIC.ai (fundamentals/ratios/EV, reconciled to filings); FactorsToday (factor loadings/leaderboard); third-party valuation-percentile and news data (validated against primary filings).

APPENDIX A — Standard Diligence Questionnaire — Installed Building Products, Inc. (NYSE: IBP)

Supplemental to the research memo. Report date: 2026-06-14. Labels: (F) Fact, (I) Interpretation, (A) Assumption.

General

What thoughtful questions have other investors asked about this company?

• Is IBP’s headline growth real, or is it masking a shrinking organic base? (Answer: 2025 organic revenue −1.3%; total +1.0% growth was 100% acquisition-funded.) (F)
• How can margins expand while volume falls — is it sustainable? (Price/mix positive every year on a variable cost base; but incremental margins turned negative in 2025, signaling a ceiling.) (F/I)
• Does the 4–6x M&A arbitrage survive now that QXO (TopBuild) and Lowe’s (ADG) are buying installers? (Open question — the key risk to the flywheel.) (I)
• Why did the CEO sell $125M near the peak, and should investors worry? (Diversification from a 13%+ holder; offset by operating-team dip buying.) (F/I)
• Is ~19x adjusted earnings too much for a single-family-cyclical at peak margins? (The central valuation debate.) (I)

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Mixed — margins are near a cyclical high (17.9% EBITDA, 34% GM) while volume is in a trough (same-branch volume −10% in Q1’26). Unlike a pure cyclical, earnings did not collapse; they were defended by price/mix and commercial. (F)

Driven by external environment or internal actions? Both — demand is external (single-family starts, rates; InterestRate factor loading −0.66), but the margin/ROIC resilience is internal (pricing discipline, variable labor, diversification, M&A). (F/I)

How stable are revenues? More stable than a distributor’s but still cyclical — revenue grew through 2022–25 (largely via M&A) while a pure-cyclical peer (BLDR) fell ~33%. Insulation is code-required and non-deferrable, which steadies demand relative to discretionary building products. (F/I)

Outlook for products/services? Residential soft near-term (entry-level builders weak; private builders turned positive April 2026); commercial strong (+22% same-branch); complementary products growing. Energy-code content tailwind rescinded. (F)

How big is the market — growing, shrinking, domestic, international? U.S.-only. Large, fragmented installation market with a long consolidation runway; long-run demand tracks household formation (~1.1–1.5M starts vs 941k now). Cyclically depressed, structurally growing. (F/I)

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Slightly more — strategic capital (QXO/TopBuild, Lowe’s/ADG) is entering installation for the first time, but the top tier remains a rational duopoly over a fragmented tail. (F/I)

How profitable is the business (ROIC, ROE)? ROIC ~17% held through the downturn (management cites ~24% on its definition); among the best in building products. ROE high but distorted by buyback-shrunk equity. (F)

How profitable is the industry — competitors, barriers? The two leaders earn high-teens ROIC; barriers are local (density, relationships, purchasing scale), not national. Material suppliers (Owens Corning, Knauf) are an oligopoly with their own pricing power. (F/I)

Can the business be easily understood? Yes — buy insulation, install it with crews, charge a spread; complexity is in local execution, pricing discipline, and the M&A machine. (I)

Can it be undermined by foreign low-cost labor? No — installation is inherently local, on-site, U.S.-based labor. (I)

Do brands matter? At the builder level, reliability/schedule/coverage matter more than brand; IBP retains acquired local brands deliberately. (I)

Nature of competition? Local, on price/service/schedule-reliability/coverage; national scale wins with production builders, locals compete on custom/regional. (I)

Customers’ switching costs? Moderate — switching installers mid-relationship risks schedule and quality on a trade that gates the rest of the build; offset by low contractual lock-in. (I)

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Local builder relationships and crew networks (the real assets) are partly captured as acquisition intangibles; much of book equity is goodwill/intangibles. (I)

Off-balance-sheet liabilities? Operating leases (capitalized); earnout/contingent consideration on acquisitions (monitor remeasurement). No unusual exposure flagged. (F)

How conservative is the accounting? High quality — point-in-time revenue, short intangible lives, no goodwill impairments, CFO > NI, GAAP EPS understated by non-cash amortization. (F)

How CapEx-hungry? Light — ~2.4% of sales; net PP&E ~$282M on ~$3.0B revenue. (F)

Capital Allocation & Management

How much FCF, and how is it used? ~$300M FCF (2025); ~1/3 to dividends, the rest to M&A (4–6x EBITDA tuck-ins) and buybacks; conservative leverage. (F)

Significant acquisitions recently? Continuous — ~7–11 deals/year; standing goal ≥$100M acquired revenue/year. (F)

Buying back shares? Yes — record $172.6M in 2025; ~14% share-count reduction since 2021; new $500M authorization Feb 2026 (mostly unused — dry powder). (F)

Issuing stock to insiders? No — modest SBC (~0.7% of sales); share count falling. (F)

Compensation policy? LTI on Adjusted EBITDA / revenue / G&A %; annual bonus on financial goals. ROIC is a narrative anchor, not a formula metric (mild weakness). CEO 2025 pay ~$9.7M. (F)

Motivations of management? Founder-led (CEO Edwards, ~13% stake — strong alignment); the $125M March-2026 sale is a flag, offset by operating-team dip buying. (F/I)

Valuation & Market Data

ADR, MLP, or K-1? No — standard U.S. C-corporation common stock (NYSE); 1099, not K-1. (F)

Dividend policy? Distinctive dual policy: regular quarterly ($0.39, +5%) plus a variable annual special ($1.80 for 2026, +6%); all-in yield ~1.6%; payout ~33%. (F)

How profitable? Net margin ~9%, EBITDA margin 17.9%, ROIC ~17% — high for the sector. (F)

Net income diverging from CFO? Yes, favorably — CFO runs 1.1–1.9x net income, mainly non-cash acquisition amortization. (F)

Risks & Downside

What would cause the stock to decline (further)? A deeper/longer single-family trough, margin give-back below ~16%, M&A-arbitrage erosion, a multiple de-rate, or disappointing organic inflection. (I)

Risk of catastrophic loss? Low — conservative balance sheet (~1.0–1.2x net debt), positive through-cycle FCF, no maturity wall, ~$900M liquidity. (F/I)

Chance of total loss? Very low — profitable, asset-light, FCF-generative; financial distress is remote. The realistic downside is a de-rating (toward ~$130), not impairment. (I/A)

Recent News & Events

Has the business environment changed recently? Yes — single-family/entry-level demand weakened sharply (Q1’26 same-branch −6%, volume −10%); commercial strengthened (+22%); the stock fell ~50%; the energy-code tailwind was rescinded. (F)

Significant acquisitions? Ongoing tuck-ins (Thermo-Tech, Carolina Precision Fibers, etc.); industry-level, QXO is acquiring TopBuild and Lowe’s bought Artisan Design Group. (F)

Change in accounting policies? None material flagged. (F)

Recent changes — markets, facilities, management? January 2026 refinancing (2034 notes, ABL extended to 2031); Feb 2026 $500M buyback authorization; CEO’s $125.6M March 2026 share sale; operating-team buys May 2026; continued commercial expansion. (F)

APPENDIX B — Source Appendix

APPENDIX B — Source Appendix — Installed Building Products, Inc. (NYSE: IBP)

Report date: 2026-06-14. As-of price $207.09 (2026-06-12). Primary sources prioritized; third-party aggregators reconciled to filings.

Primary — SEC Filings (EDGAR, CIK 0001580905)

Primary — Earnings Call Transcripts (via ROIC.ai)

Third-Party Data (reconciled to filings)

Industry / Transaction & Regulatory References (public)